Prototyping a Device for Automating Stool and Urine Output Tracking
Launched by DUKE UNIVERSITY · Jun 24, 2022
Trial Information
Current as of August 20, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new electronic device designed to help measure how much stool and urine a person produces in an easy and accurate way. The goal is to make tracking waste output simpler for individuals. To participate, you need to be a student or employee at Duke University and have access to specific private bathrooms in the CIEMAS or MSRB III buildings. You should also be able to use these bathrooms safely and comfortably.
If you decide to join the study, you will have one visit with the research team before starting. Once enrolled, you can choose when to use the device in the private bathroom during the testing period. It's important to note that if you use a wheelchair or other mobility aids, you won't be able to participate at this time due to the current bathroom setup not meeting accessibility standards.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • people who are able to use the private bathroom at no risk to themselves in the CIEMAS building (B508) or the bathroom located in room 4002, 4th floor of MSRB3.
- • students or employees at Duke University since card access is required for our MSRB3 bathroom.
- • people who spend most of their time in these buildings so we can assure the use of the toilet.
- • If the recruitment number is slow, enrollment will include people from the closest buildings.
- Exclusion Criteria:
- • People who use wheelchairs or other mobility devices won't be able to enroll, since at this moment the bathroom is not compliant with the requirements on The Americans with Disabilities Act (ADA) of 1990.
About Duke University
Duke University, a leading academic and research institution located in Durham, North Carolina, is renowned for its commitment to advancing healthcare through innovative clinical research. With a strong emphasis on interdisciplinary collaboration, Duke conducts a wide array of clinical trials aimed at developing cutting-edge therapies and improving patient outcomes across various medical fields. The university's Clinical Research Institute provides comprehensive support for trial design, implementation, and regulatory compliance, ensuring that all research adheres to the highest ethical and scientific standards. Duke’s dedication to translating research findings into effective clinical practices underscores its role as a pivotal contributor to the global medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Durham, North Carolina, United States
Patients applied
Trial Officials
Lawrence David
Principal Investigator
Duke University - MGM
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials